Finance News – Obesity Drug
What is your interest today?
Bitcoin
Crypto
Btc
Stocks
Shares
Tariffs
Investors
Stock
Ceo
Stock Market
Crypto Assets
Ethereum
Cryptocurrency
Price
Markets
Xrp
Eth
Bse
Etf
Earnings
Stablecoin
Ipo
Investment
Blockchain
Revenue
Index
Solana
Trade
Sec
Interest Rates
Inflation
Token
Wall Street
Sensex
Coinbase
Treasury
Federal Reserve
Nasdaq
Traders
Nse
Profit
Bse Sensex
China
Nifty
Sp 500
Gold
Investor
Tesla
Company
Economy
Jubilant Ingrevia
Opyn
Vehicle Making
Ibit Holdings
Gas Meter
Crypto Investing
Alt
Domestic Policy Bill
Mac Exploit
Russian Crude
= 1024) { setSearchBy('title'); suggestionOpen = true; fetch() }"
@input.debounce.300ms="window.innerWidth >= 1024 && fetch()"
@keydown.enter.prevent="window.innerWidth >= 1024 && submitSearch()"
placeholder="Search finance news…"
class="flex-grow bg-transparent border-0 focus:ring-0 px-4 py-2 placeholder-gray-500 dark:placeholder-gray-400 text-gray-900 dark:text-gray-100 mr-2"
/>
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
CNBC Business • Jul 16, 2025
Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly’s Zepbound
The success of a new obesity medication in China could challenge existing market leaders, potentially shifting investment dynamics within the pharmaceutical sector and impacting fu...
Read Full Article →
CNBC Business • Jun 24, 2025
Abbott jumps on RFK Jr. health push — plus, reviews of Eli Lilly's obesity drug data
Abbott’s recent involvement in supporting RFK Jr.’s health initiatives, along with the evaluation of Eli Lilly’s obesity medication findings, may influence market trends and invest...
Read Full Article →